| Revisiting the time needed to provide adult primary care J Porter, C Boyd, MR Skandari, N Laiteerapong Journal of general internal medicine 38 (1), 147-155, 2023 | 250 | 2023 |
| Total flow time minimization in a flowshop sequence-dependent group scheduling problem N Salmasi, R Logendran, MR Skandari Computers & Operations Research 37 (1), 199-212, 2010 | 130 | 2010 |
| Cost-effectiveness of continuous glucose monitoring for adults with type 1 diabetes compared with self-monitoring of blood glucose: the DIAMOND randomized trial W Wan, MR Skandari, A Minc, AG Nathan, A Winn, P Zarei, M O’Grady, ... Diabetes care 41 (6), 1227-1234, 2018 | 121 | 2018 |
| Timing of arteriovenous fistula creation in patients with CKD: a decision analysis SM Shechter, MR Skandari, N Zalunardo American journal of kidney diseases 63 (1), 95-103, 2014 | 86 | 2014 |
| First-line therapy for type 2 diabetes with sodium–glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a cost-effectiveness study JG Choi, AN Winn, MR Skandari, MI Franco, EM Staab, J Alexander, ... Annals of internal medicine 175 (10), 1392-1400, 2022 | 68 | 2022 |
| Makespan minimization of a flowshop sequence-dependent group scheduling problem N Salmasi, R Logendran, MR Skandari The International Journal of Advanced Manufacturing Technology 56, 699-710, 2011 | 57 | 2011 |
| An integrated ant colony optimization approach to compare strategies of clearing market in electricity markets: Agent-based simulation A Azadeh, MR Skandari, B Maleki-Shoja Energy Policy 38 (10), 6307-6319, 2010 | 46 | 2010 |
| Individualized glycemic control for US adults with type 2 diabetes: a cost-effectiveness analysis N Laiteerapong, JM Cooper, MR Skandari, PM Clarke, AN Winn, ... Annals of internal medicine 168 (3), 170-178, 2018 | 45 | 2018 |
| The impact of biomarker screening and cascade genetic testing on the cost-effectiveness of MODY genetic testing MS GoodSmith, MR Skandari, ES Huang, RN Naylor Diabetes Care 42 (12), 2247-2255, 2019 | 44 | 2019 |
| The longer-term benefits and harms of glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis JT Alexander, EM Staab, W Wan, M Franco, A Knitter, MR Skandari, ... Journal of general internal medicine, 1-24, 2022 | 28 | 2022 |
| Cost-effectiveness of initiating an insulin pump in T1D adults using continuous glucose monitoring compared with multiple daily insulin injections: the DIAMOND randomized trial W Wan, MR Skandari, A Minc, AG Nathan, P Zarei, AN Winn, M O’Grady, ... Medical Decision Making 38 (8), 942-953, 2018 | 23 | 2018 |
| Cost-effectiveness of shared telemedicine appointments in young adults with T1D: CoYoT1 trial W Wan, AG Nathan, MR Skandari, P Zarei, MW Reid, JK Raymond, ... Diabetes Care 42 (8), 1589-1592, 2019 | 22 | 2019 |
| Patient-type Bayes-adaptive treatment plans MR Skandari, SM Shechter Operations research 69 (2), 574-598, 2021 | 21 | 2021 |
| Optimal vascular access choice for patients on hemodialysis MR Skandari, SM Shechter, N Zalunardo Manufacturing & Service Operations Management 17 (4), 608-619, 2015 | 17 | 2015 |
| The productivity requirements of implementing a medical scribe program TJ Miksanek, MR Skandari, SA Ham, WW Lee, VG Press, MT Brown, ... Annals of Internal Medicine 174 (1), 1-7, 2021 | 16 | 2021 |
| Longer-term benefits and risks of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a systematic review and meta-analysis JT Alexander, EM Staab, W Wan, M Franco, A Knitter, MR Skandari, ... Journal of general internal medicine, 1-10, 2022 | 15 | 2022 |
| Cost-effectiveness analysis of vascular access referral policies in CKD SM Shechter, T Chandler, MR Skandari, N Zalunardo American Journal of Kidney Diseases 70 (3), 368-376, 2017 | 15 | 2017 |
| Development and validation of a decision analytical model for posttreatment surveillance for patients with oropharyngeal carcinoma V Nair, S Auger, S Kochanny, FM Howard, D Ginat, O Pasternak-Wise, ... JAMA Network Open 5 (4), e227240-e227240, 2022 | 6 | 2022 |
| Expected health benefits of SGLT-2 inhibitors and GLP-1 receptor agonists in older adults RS Dadwani, W Wan, MR Skandari, ES Huang MDM Policy & Practice 8 (2), 23814683231187566, 2023 | 4 | 2023 |
| Alternative type 2 diabetes screening tests may reduce the number of US adults with undiagnosed diabetes RS Dadwani, MR Skandari, MS GoodSmith, LS Phillips, MK Rhee, ... Diabetic Medicine 37 (11), 1935-1943, 2020 | 4 | 2020 |
Elbert S. Huang, MD, MPH, FACPProfessor of Medicine, University of ChicagoZweryfikowany adres z medicine.bsd.uchicago.edu
